This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.90% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
3 MedTech Stocks Benefiting From Favorable Product Mix Shifts
by Indrajit Bandyopadhyay
ANGO, BSX and MDT are showing earnings quality improve as higher-margin products take share, supporting margins and durable growth across MedTech.
BSXNegative Net Change ANGONegative Net Change MDTNegative Net Change
medical medical-devices
NTRA & NVDA Partner to Improve AI Models for Precision Medicine
by Zacks Equity Research
Natera teams up with NVIDIA to train multimodal AI models, aiming to improve precision care through faster, scalable analysis of complex medical data.
NVDAPositive Net Change VCYTNegative Net Change CDNANegative Net Change NTRAPositive Net Change
medical medical-devices
Plains All American Pipeline (PAA) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
PAAPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Are Options Traders Betting on a Big Move in WAT Stock?
by Zacks Equity Research
Investors need to pay close attention to Waters stock based on the movements in the options market lately.
WATPositive Net Change
medical-devices
Implied Volatility Surging for CareDx Stock Options
by Zacks Equity Research
Investors need to pay close attention to CareDx stock based on the movements in the options market lately.
CDNANegative Net Change
medical medical-devices
Should You Buy, Sell or Hold TLRY Stock Post Q2 Earnings?
by Moumi Mondal
Tilray Brands posts record Q2 revenue of $217.5M, beats sales estimates, reaffirms EBITDA outlook as international cannabis and distribution offset beverage weakness.
CGCPositive Net Change TLRYPositive Net Change ACBNegative Net Change
medical medical-devices
Zacks Industry Outlook Highlights Medpace, Enhabit and Progyny
by Zacks Equity Research
Medpace anchors a cautious medical services outlook as digital health tailwinds help select players offset workforce pressures.
MEDPPositive Net Change PGNYNegative Net Change EHABPositive Net Change
medical-devices
Hims & Hers Expands Platform-Led Access to Provider-Directed Care
by Debanjana Dey
HIMS broadens access to provider-led care with new offerings in diagnostics, hormonal health and at-home testing.
MEDPositive Net Change GDRXNegative Net Change HIMSNegative Net Change
medical medical-devices
GeneDx Partners With Komodo Health to Advance Rare Disease Research
by Zacks Equity Research
WGS collaborates with Komodo Health to link genomic data with real-world insights, expanding data monetization and strengthening its role in rare disease research.
BSXNegative Net Change ISRGNegative Net Change MEDPPositive Net Change WGSNegative Net Change
medical medical-devices
RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models
by Zacks Equity Research
Revvity teams up with Eli Lilly to bring TuneLab AI models to Signals Xynthetica, aiming to unlock secure, federated drug discovery at scale.
CRLPositive Net Change VCYTNegative Net Change CDNANegative Net Change RVTYPositive Net Change
medical medical-devices
Take the Zacks Approach to Beat the Markets: Indivior, FIGS & Ulta Beauty in Focus
by Santanu Roy
Zacks highlights how Indivior, FIGS and Ulta Beauty delivered outsized gains as its ranks, recommendations and focus lists beat a volatile market.
ACNNegative Net Change MMMPositive Net Change SBUXPositive Net Change FORMNegative Net Change ULTAPositive Net Change HIIPositive Net Change AMKRPositive Net Change MTDNegative Net Change FIVENegative Net Change NOBLPositive Net Change FIGSPositive Net Change INDVNegative Net Change
aerospace computers medical medical-devices multi-sector-conglomerates restaurants retail semiconductor
Illumina's New Connected Multiomics Platform Set to Boost Its Stock
by Zacks Equity Research
ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.
BSXNegative Net Change ILMNPositive Net Change IDXXNegative Net Change STENegative Net Change
medical medical-devices
3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds
by Indrajit Bandyopadhyay
Cardinal Health, McKesson, and Cencora are showing how scale, specialty focus, and execution can drive market-beating returns despite macro pressure.
CAHPositive Net Change MCKNegative Net Change CORPositive Net Change
medical medical-devices
Neogen's Q2 Earnings and Revenues Beat Estimates, Stock Climbs
by Zacks Equity Research
NEOG's Q2 EPS and revenues top estimates, sending shares up 31.6% as the company raises its fiscal 2026 revenue and EBITDA outlook.
MDTNegative Net Change FMSNegative Net Change PBHNegative Net Change NEOGNegative Net Change
earnings medical medical-devices
PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities
by Zacks Equity Research
PACB introduces CiFi, a new sequencing method designed to expand multiomics capabilities without added hardware.
BSXNegative Net Change CAHPositive Net Change IDXXNegative Net Change PACBPositive Net Change
medical medical-devices
SENS Stock Up as Eversense 365 Enters AID Market With twiist System
by Zacks Equity Research
Senseonics shares gain after Eversense 365 became the first one-year implantable CGM integrated with an automated insulin delivery system.
BSXNegative Net Change ISRGNegative Net Change SENSPositive Net Change MEDPPositive Net Change
medical medical-devices
3 MedTech Stocks That Crushed the S&P 500 Over the Past Year
by Indrajit Bandyopadhyay
TransMedics, KORU Medical Systems and Cardinal Health beat the S&P 500 as execution, earnings visibility and company-specific catalysts drove gains.
CAHPositive Net Change TMDXPositive Net Change KRMDNegative Net Change
medical medical-devices
Can da Vinci 5 Expand Intuitive Surgical's TAM Beyond Core Surgeries?
by Indrajit Bandyopadhyay
ISRG is positioning da Vinci 5 as a TAM expander, targeting cardiac surgery long term while advancing near-term regulatory steps in general surgery.
JNJPositive Net Change MDTNegative Net Change ISRGNegative Net Change
medical medical-devices
Is it the Right Time to Add STERIS Stock to Your Portfolio?
by Zacks Equity Research
STE is buoyed by strong Healthcare and AST growth, solid margins and balance sheet strength, even as macro pressures and competition loom.
BSXNegative Net Change DGXPositive Net Change STENegative Net Change PAHCPositive Net Change
medical medical-devices
SLP Stock Crashes on Q1 Earnings Miss, Software Headwinds Hurt Sales
by Zacks Equity Research
Simulations Plus Q1 fiscal 2026 EPS miss as software revenue fall 17%, but services momentum and strong bookings support confidence for the rest of fiscal 2026.
CIENPositive Net Change SLPPositive Net Change GWRENegative Net Change BBNegative Net Change
computers earnings medical-devices smart-health tech-stocks
Should You Buy Electrolux AB (ELUXY) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ELUXYPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Hims & Hers Plunges 39.2% in 3 Months: Time to Hold the Stock or Sell?
by Debanjana Dey
HIMS expands into Canada and the U.K. while revenue and subscribers grow. However, margins and execution raise concerns.
TDOCNegative Net Change HIMSNegative Net Change DOCSNegative Net Change
medical medical-devices
INGN Stock Gains Post Latest Launch to Expand Respiratory Care Suite
by Zacks Equity Research
Inogen launches Aurora CPAP masks to expand its respiratory care suite and enter the growing sleep apnea market.
BSXNegative Net Change CAHPositive Net Change IDXXNegative Net Change INGNPositive Net Change
medical medical-devices
Implied Volatility Surging for Accendra Health Stock Options
by Zacks Equity Research
Investors need to pay close attention to ACH stock based on the movements in the options market lately.
ACHNegative Net Change
medical medical-devices
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
by Zacks Equity Research
AVTR looks worth holding as its broad portfolio, strategic deals and cost savings offset Lab Solutions' weakness for now with AI tools and strong cash flow.
BSXNegative Net Change ISRGNegative Net Change MEDPPositive Net Change AVTRPositive Net Change
medical medical-devices